Dublin, Aug. 22, 2017 -- The "USA Pediatric Proton Therapy Market: Patient Numbers, Forecast by Age & Tumors (36 Cancer Types Analyzed)" report has been added to Research and Markets' offering.
USA Pediatric Proton Therapy Market has potential to reach close to US$ 350 Million by the end of year 2021. But its actual market is predicted to be less than even half of this figure. The difference between this actual and potential market is due to its demand and supply gap. In United States, the cancer incidence among pediatric is rising at rapid pace. USA has largest and more efficient proton therapy center in world due to long history of its proton therapy research and huge investment on center development.
Age Group of (1-4) has the Largest Cancer Evidence in USA Pediatric Proton Therapy Market
In this report United States pediatric proton therapy market is divided into five age group (<1) Year, (1-4) Year, (5-9) Year, (10-14) Year, (15-18) Year. Out of these age groups (1-4) age group has largest market.
Ependymoma Cancerous Tumor has the Highest Market among 36 Types of Cancer which has been studied in the report
The largest treated pediatric patient with proton therapy in USA is Ependymoma which has almost 15 percent share in United States pediatric proton therapy market. Moreover the ability of proton therapy to treat numerous types of pediatric cancer in a more efficient way than traditional radiotherapy has made it preferential choice for pediatric cancer patients.
Increasing Cancer Incidence Among Pediatric and Phenomenal Progress in Technological Development of Proton Therapy Across the Period of Time has made it Key driver for Rapid Growth in United States
Proton Therapy has gained prominence in such a short period due to continuous development of cutting-edge technology like intensity-modulated proton therapy (IMPT) and pencil beam technology. Moreover rising cancer incidence among children in United States reinforced pediatric proton therapy market for faster growth.
'USA Pediatric Proton Therapy Market, Patient Numbers, Forecast By Age & Tumors (36 Cancer Types Analyzed)' is the 16th report published on Proton Therapy Market. This 195 page report with 182 figures and 3 Tables provides: Pediatric Proton Therapy Market, Proton Therapy Patient Numbers (both by Age Group and Type of Tumors) Technology being used at these Proton Therapy Centers. The report also studies the Proton Therapy Sales & Forecast of four companies IBA, Varian Medical Systems, Mitsubishi and Hitachi.
Type of Tumors Market & Patient Numbers Studied in the Report:
1. Glioma, Low Grade
2. Glioma, High Grade
3. Medulloblastoma
4. Ependymoma
5. ATRT
6. Germinoma, Pure
7. Germ Cell Tumor
8. Craniopharyngioma
9. PNET
10. Pineoblastoma
11. Chordoma/Chondrosarcoma
12. Meningioma
13. AVM
14. Adenoma
15. Choroid Plexus Carcinoma
16. Retinoblastoma
17. Osteosarcoma
18. Ewing Sarcoma
19. Rhabdomyosarcoma
20. Other Sarcoma, High Grade
21. Other Sarcoma, Low Grade
22. Teratoma
23. Neuroblastoma
24. Ganglioglioma
25. Wilm's Tumor
26. Carcinoma (non-CPC)
27. Lymphoma, Hodgkin's
28. Lymphoma, Non-hodgkin's
29. Leukemia
30. Desmoid
31. Melanoma
32. Pineal Parenchymal Tumor
33. Esthesioneuroblastoma
34. Angiofibroma
35. Extrarenal Rhabdoid Tumor
36. Others
Age Group Studied in Report:
1. Age Group (<1) Year
2. Age Group (1-4) Year
3. Age Group (5-9) Year
4. Age Group (10-14) Year
5. Age Group (15-18) Year
Key Companies Proton Therapy Sales & Forecast (2010 - 2021) Covered in this report:
1. IBA
2. Varian Medical Systems
3. Mitsubishi
4. Hitachi
Key Questions Answered in the Report?
- What is the Pediatric Proton Therapy Market in United States and its growth potential in Future?
- How Many Pediatric Patients are treated by Proton Beam Therapy in United States?
- What is the Pediatric Proton Therapy Market by Age Group age group (<1) Year, (1-4) Year, (5-9) Year, (10-14) Year, (15-18) Year in United States and its Forecast?
- How Many Pediatric Proton Therapy Patients treated by Age Group age group (<1) Year, (1-4) Year, (5-9) Year, (10-14) Year, (15-18) Year in United States and its Forecast?
- What is the Pediatric Proton Therapy Market by Tumors (36 Types) in United States and its Forecast?
- How Many Pediatric Proton Therapy Patients treated by different Tumor Type in United States and its Forecast?
- What Type of Technology is being used at Proton Therapy Centers?
Note: This report offers 10% free customization.
Key Topics Covered:
1. Research Findings
2. United States Pediatric Proton Therapy Market (Actual & Potential)
2.1 United States Pediatric Proton Therapy Market & Forecast
2.2 United States Potential Pediatric Proton Therapy Market & Forecast
3. USA Pediatric Proton Therapy Market by Age Group
3.1 By Age Group (List of Figures
Figure 2-1: United States - Pediatric Proton Therapy Market (Million US$), 2010 - 2016
Figure 2-2: United States - Forecast for Pediatric Proton Therapy Market (Million US$), 2017 - 2021
Figure 2-3: United States - Potential Pediatric Proton Therapy Market (Million US$), 2010 - 2016
Figure 2-4: United States - Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 - 2021
Figure 3-1: United States - Pediatric Proton Therapy Market by Age Group (List of Tables
Table 11 1: Global - IBA Proton Therapy Centers in Operational and Under-Construction Phase
Table 11 2: Global - Mitsubishi Proton Therapy Centers in Operational and Under-Construction Phase
Table 11 3: Global - Hitachi Proton Therapy Centers in Operational and Under-Construction Phase
Companies Mentioned
- Hitachi
- IBA Proton Therapy
- Mitsubishi Electric Corporation
- Varian Medical Systems
For more information about this report visit https://www.researchandmarkets.com/research/vmhm6x/usa_pediatric
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Oncology Drugs , Nuclear Medicine and Radiopharmacology, Pediatrics


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Washington Post Publisher Will Lewis Steps Down After Layoffs
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



